NCNA vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

NCNA

41.2
AI Score
VS
NCNA Wins

CLYM

31.0
AI Score

Investment Advisor Scores

NCNA

41score
Recommendation
HOLD

CLYM

31score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric NCNA CLYM Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 0.0% Tie
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 41.2/100 31.0/100 NCNA
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY NCNA

Relative Price Performance (Last 90 Days)

NCNA 1M: -8.2% · 3M: -39.6% CLYM 1M: -4.0% · 3M: -40.0%

Current Technical Phase

NCNA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.2%), weak momentum, RSI 38

RSI (14): 38.4 · Price: $0.94

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.3 · Price: $10.47

Fundamentals Snapshot

Metric NCNA CLYM
Market Cap — —
Forward P/E -17.9 -10.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS 0.00 -0.81
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NCNA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.